68Ga-BCMA PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-BCMA PET/CT, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma. [Phase 2, Phase 3]